LJHT
Laurie J. Hall Trustee Portfolio holdings
AUM
$302M
This Quarter Return
+11.25%
1 Year Return
+17.68%
3 Year Return
+82.52%
5 Year Return
+131.39%
10 Year Return
–
AUM
$284M
AUM Growth
+$284M
(+8.8%)
Cap. Flow
-$907K
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
262
New
5
Increased
22
Reduced
73
Closed
10
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$1.79M |
| 2 |
TJX Companies
TJX
|
$490K |
| 3 |
Walmart
WMT
|
$292K |
| 4 |
Veralto
VLTO
|
$266K |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
$234K |
Top Sells
| 1 |
AbbVie
ABBV
|
$504K |
| 2 |
Microsoft
MSFT
|
$485K |
| 3 |
Advanced Micro Devices
AMD
|
$400K |
| 4 |
Merck
MRK
|
$348K |
| 5 |
NVIDIA
NVDA
|
$317K |
Sector Composition
| 1 | Technology | 30.18% |
| 2 | Healthcare | 23.51% |
| 3 | Industrials | 13.8% |
| 4 | Consumer Staples | 7.75% |
| 5 | Consumer Discretionary | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Medtronic
MDT
$119B
| $3.84M | 1.35% | 44,015 +125 | +0.3% | +$10.9K |
|
27
Canadian National Railway
CNI
$60.4B
| $3.8M | 1.34% | 28,857 +140 | +0.5% | +$18.4K |
|
28
AptarGroup
ATR
$9.18B
| $3.76M | 1.33% | 26,155 +555 | +2% | +$79.9K |
|
29
Nike
NKE
$114B
| $3.62M | 1.28% | 38,530 +1,435 | +4% | +$135K |
|
|
30
Merck
MRK
$210B
| $3.48M | 1.22% | 26,359 -2,641 | -9% | -$348K |
|
31
New York Times
NYT
$9.74B
| $3.24M | 1.14% | 74,860 +410 | +0.6% | +$17.7K |
|
32
Fiserv
FI
$75.1B
| $2.95M | 1.04% | 18,465 +450 | +2% | +$71.9K |
|
|
33
AbbVie
ABBV
$372B
| $2.86M | 1.01% | 15,730 -2,770 | -15% | -$504K |
|
34
Becton Dickinson
BDX
$55.3B
| $2.76M | 0.97% | 11,142 +175 | +2% | +$43.3K |
|
35
Unilever
UL
$155B
| $2.74M | 0.97% | 54,583 -1,408 | -3% | -$70.7K |
|
36
Novartis
NVS
$245B
| $2.68M | 0.94% | 27,657 -140 | -0.5% | -$13.5K |
|
37
Sysco
SYY
$38.5B
| $2.55M | 0.9% | 31,432 -750 | -2% | -$60.9K |
|
38
Amazon
AMZN
$2.44T
| $2.49M | 0.88% | 13,790 -330 | -2% | -$59.5K |
|
39
3M
MMM
$82.8B
| $2.23M | 0.79% | 21,072 -1,694 | -7% | -$180K |
|
40
SPDR S&P 500 ETF Trust
SPY
$658B
| $2.22M | 0.78% | 4,242 | – | – |
|
41
Air Products & Chemicals
APD
$65.5B
| $1.98M | 0.7% | 8,155 -5 | -0.1% | -$1.21K |
|
|
42
Vertex Pharmaceuticals
VRTX
$100B
| $1.92M | 0.68% | 4,585 +4,285 | +1,428% | +$1.79M |
|
43
iShares MSCI EAFE ETF
EFA
$66B
| $1.91M | 0.67% | 23,925 | – | – |
|
44
Amgen
AMGN
$155B
| $1.87M | 0.66% | 6,580 -550 | -8% | -$156K |
|
45
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $1.82M | 0.64% | 36,188 | – | – |
|
46
Emerson Electric
EMR
$74.3B
| $1.74M | 0.61% | 15,375 -350 | -2% | -$39.7K |
|
47
Parker-Hannifin
PH
$96.2B
| $1.69M | 0.59% | 3,033 | – | – |
|
48
PACCAR
PCAR
$52.5B
| $1.66M | 0.58% | 13,371 | – | – |
|
49
Vanguard Total International Stock ETF
VXUS
$102B
| $1.52M | 0.54% | 25,214 +1,700 | +7% | +$103K |
|
50
Crown Holdings
CCK
$11.6B
| $1.51M | 0.53% | 19,055 +365 | +2% | +$28.9K |
|